Search

2.1 Cross-cutting pharmaceutical quality assurance issues Expert Committee on the Selection and Use of Essential Medicines The Expert Committee on the Selection and Use of Essential Medicines selects the medicines [...]

Geneva, 12-16 October 2015 Members (1) Professor Saleh A. Bawazir, Consultant, College of Pharmacy, King Saud Unit, Riyadh, Saudi Arabia (Rapporteur) Professor Theo G. Dekker, Professor Emeritus, Research Institute for [...]

Introduction Thiomersal (also known as thimerosal, merthiolate) is an organomercurial derivative of ethylmercury that has been used very widely, and for a very long time, as a preservative in vaccines [...]

Introduction The concept of essential medicines Essential medicines are those that satisfy the priority health care needs of the population. They are selected with due regard to public health relevance, [...]

Antiretroviral medicines Evidence provided to the WHO Expert Committee on the Selection and Use of Essential Medicines in support of the application to include 12 antiretroviral (ARV) medicines in the [...]

The following list provides the corresponding Anatomical Therapeutic Chemical (ATC) classification codes for all items on the 12th WHO Model List of Essential Medicines, sorted by ATC code number. ATC [...]

Proposals for amendments to the Model List, including applications for additions and deletions, received by the Committee for consideration at its present meeting are summarized below. 6.1 Applications for additions [...]

8.1 Procedures for updating and disseminating the Model List of Essential Medicines (1) 1. Applications for inclusions, changes or deletions may be submitted to the Secretariat of the Expert Committee [...]

4.1 Change of name of the Expert Committee The first Expert Committee, convened in 1977 was called the "WHO Expert Committee on the Selection of Essential Drugs" and its meeting [...]

3.1 Background At its previous meeting held in 1999, the Committee reviewed past experience with the Model List and discussed future needs (2). It noted that: --with regard to the [...]

12.1 Launch of The International Pharmacopoeia, Volume 5 The new volume of The International Pharmacopoeia was presented to the Committee. This document includes 72 new monographs, 15 of which are [...]

5.1 Section headings At present, medicines on the Model List are listed alphabetically under 27 main therapeutic use categories. Although this system of sectioning may not have the rigour of [...]

10.1 Update on the Prequalification Team managed by WHO The Prequalification Programme was launched by WHO in 2001 in partnership with the Joint United Nations Programme on HIV/AIDS (UNAIDS), UNICEF [...]

1. Introduction A WHO Expert Consultation on Rheumatic Fever (RF) and Rheumatic Heart Disease (RHD) met in WHO/HQ, Geneva from 29 October to 1 November 2001 to update the WHO [...]

The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 10 to 14 March 2003. Dr A. Asamoa-Baah, Executive Director, Health Technology and Pharmaceuticals, welcomed the Committee [...]

(1.) Pilot procurement, quality and sourcing project: access to H/V/AIDS drugs and diagnostics of acceptable quality, 4th ed. Geneva, World Health Organization, 2002 (regularly updated; available from the Internet at [...]

7.1 Update on the review of medicines for the treatment of hypertension The Committee was informed of progress in updating the existing clinical guidelines for the treatment of hypertension (21) [...]

The open session was opened by Dr Y. Suzuki, Executive Director, Health Technology and Pharmaceuticals, who stated that this meeting should be seen in the light of other related activities, [...]

The Committee recognized the large contribution to the process of evidence-based selection of essential medicines made by the late Professor James Petrie. The Committee expressed its appreciation of the contributions [...]

The WHO Expert Committee on the Use of Essential Drugs met in Geneva from 15 to 19 April 2002. The meeting was opened on behalf of the Director-General by Dr [...]